134 results
6-K
EX-99.2
THTX
Theratechnologies Inc.
15 Apr 24
Notice of Annual Meeting of Shareholders
9:31am
of financial targets and corporate milestones each accounted for 30% of the total bonus.
Financial targets were based as to 15% on the attainment of pre … EBITDA”) targets. The Adjusted EBITDA targets are not disclosed since the Corporation did not provide any specific Adjusted EBITDA targets as part
6-K
EX-99.2
THTX
Theratechnologies Inc.
10 Apr 24
Interim Consolidated Financial Statements
8:30am
, the “Marathon Adjusted EBITDA”) targets over the most recently ended four fiscal quarters; and, (ii) quarterly minimum Marathon Adjusted EBITDA targets
6-K
EX-99.1
THTX
Theratechnologies Inc.
10 Apr 24
Interim Consolidated Financial Statements
8:30am
on the Marathon adjusted EBITDA (as defined in the Marathon Credit Agreement, the “Marathon Adjusted EBITDA”) targets over the most recently ended four fiscal … quarters; and (ii) quarterly minimum Marathon Adjusted EBITDA targets. There is no assurance that the lender will agree to amend or to waive any
6-K
EX-99.1
THTX
Theratechnologies Inc.
10 Apr 24
Theratechnologies Reports Financial Results
8:16am
EBITDA”) targets over the most recently ended four fiscal quarters; and, (ii) quarterly minimum Marathon Adjusted EBITDA targets There is no assurance
6-K
EX-99.1
w8ft dg04d883ij3cxvr
21 Feb 24
Theratechnologies Reports Financial Results
8:00am
6-K
EX-99.1
9dqdb3d1e9u us
15 Feb 24
Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
8:36am
SUPPL
osyp9nju
26 Oct 23
Supplemental materials (foreign)
9:13pm
SUPPL
rsmk9er83aag24vt 12
25 Oct 23
Supplemental materials (foreign)
6:56pm
6-K
EX-99.1
j0i o7nn846
16 Oct 23
Theratechnologies Announces Finalization of Amendments to Some of the Terms and Conditions of its Credit Agreement with Marathon
3:04pm
6-K
EX-99.1
j1izo9wwxwn3hu7rduu
26 Sep 23
Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
8:02am
6-K
EX-99.1
dhnfc3
26 Sep 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.2
g30g40dxt8pku7e0
26 Sep 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
dwhqrgxhb6j4lmb44
28 Jul 23
Theratechnologies Announces Amendments to its Term Loan Facility With Affiliates of Marathon Asset Management
5:20pm
6-K
EX-99.2
p6u2qb
12 Jul 23
Interim Consolidated Financial Statements
8:02am